Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Home - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 392479 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Printer Friendly
PDF Brochure
Send to Friend
Enquire before Buying
Hard CopyAdd to Basket
ElectronicAdd to Basket
Site LicenseAdd to Basket



Cardiac Markers - Making their Mark on the Medicines Market
Datamonitor, Jan 2002


  Description  
  Table of Contents  
    
    
    
   
 Enquire before Buying  
 Send to a Friend  

This brief sets out to: * Review the available diagnostic markers for cardiac ischemia, atherosclerotic disease, heart failure, and platelet function. The four classes of cardiac markers are presented in order of their respective market size, with ischemia markers representing the largest market, and markers of platelet function the smallest. * Analyze each class of marker with respect to accuracy, convenience, usefulness, cost, and inherent shortcomings and/or limitations, and provide a rating for each class based on these parameters * consider the commercial implications of each class of cardiac marker, including the likely impact(s) on the existing CV diagnostics and therapeutics markets * discuss the future role of genetic analysis in shaping the diagnostics and therapeutics markets, with attention paid to genetic markers currently under investigation.



Customers who bought this item also bought

Emerging CV Market: Cell Transplant Therapies - The End of the Beginning

Treatment Algorithms 2001: Schizophrenia - The Rise of Atypical Neuroleptics as the Physicians� Favorite

Treatment Algorithms 2002: Alzheimer's Disease - Aricept: the physicians choice

Strategic Perspectives 2002: Endometriosis

Stakeholder Opinions: HIV Vaccines - The Emperor Has No Clothes

Strastegic Perspectives 2001: Diabetic Hypertension - Towards Aggressive, Individual and Holistic Treatment Strategies

HIV Update 2001 (3) - The impact of resistance testing

Market Dynamics 2001: Anti-hypertensives - Aiirbs battle for supremacy

Drugs of Tomorrow 2001: Neuroprotection - Future Strategies for Success

Drugs of Tomorrow: Anti-asthmatics - Enter the mAbs

Drugs, Devices and Procedures of Tomorrow: Acute Stroke - Chasing the need for speed

Cardiac Marker Diagnostic Testing Markets



Top of page


   All rights reserved. � Copyright 2008 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster


Research and Markets RSS Feeds